Armata Pharmctcl Stock Price, News & Analysis
ARMP
NYSE
Company Description
Welcome to the overview page for Armata Pharmctcl (ARMP), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$6.40
+0.63%
+0.04
Last updated: December 30, 2025 at 09:30
234.74 %
Performance 1 year
$239.6M
36.4M
Latest News
SEC Filings
Financial Highlights
$5,174,000
Revenue (TTM)
-$18,916,000
Net Income (TTM)
-$0.89
-$37,551,000
Operating Cash Flow
-365.60%
-820.18%
Upcoming Events
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 3 AP-SA02 trial start
Planned Phase 3 AP-SA02 trial subject to FDA review in 2026
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 3 trial initiation
Planned Phase 3 superiority trial for AP-SA02, subject to FDA feedback
JAN
01
January 1, 2026 - December 31, 2026
Clinical
Phase 3 pivotal trial start
Initiation of Phase 3 pivotal diSArm trial
MAR
12
March 12, 2026
Financial
Credit agreement matures
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Armata Pharmctcl (ARMP)?
The current stock price of Armata Pharmctcl (ARMP) is $6.36 as of December 29, 2025.
What is the market cap of Armata Pharmctcl (ARMP)?
The market cap of Armata Pharmctcl (ARMP) is approximately 239.6M. Learn more about what market capitalization means .
What is the revenue (TTM) of Armata Pharmctcl (ARMP) stock?
The trailing twelve months (TTM) revenue of Armata Pharmctcl (ARMP) is $5,174,000.
What is the net income of Armata Pharmctcl (ARMP)?
The trailing twelve months (TTM) net income of Armata Pharmctcl (ARMP) is -$18,916,000.
What is the earnings per share (EPS) of Armata Pharmctcl (ARMP)?
The diluted earnings per share (EPS) of Armata Pharmctcl (ARMP) is -$0.89 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Armata Pharmctcl (ARMP)?
The operating cash flow of Armata Pharmctcl (ARMP) is -$37,551,000. Learn about cash flow.
What is the profit margin of Armata Pharmctcl (ARMP)?
The net profit margin of Armata Pharmctcl (ARMP) is -365.60%. Learn about profit margins.
What is the operating margin of Armata Pharmctcl (ARMP)?
The operating profit margin of Armata Pharmctcl (ARMP) is -820.18%. Learn about operating margins.
What is the current ratio of Armata Pharmctcl (ARMP)?
The current ratio of Armata Pharmctcl (ARMP) is 0.23, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Armata Pharmctcl (ARMP)?
The operating income of Armata Pharmctcl (ARMP) is -$42,436,000. Learn about operating income.